Search

for
Search:

Sort by

Research

330-360 / 1000+ results

Acute And Subacute Skin Manifestations Of Systemic Lupus Erythematosus Are Associated With An Earlier Response To Belimumab Than The Chronic Phenotype: Preliminary Data From The New Nation-Wide Cohort Of Belimumab In Real Life Setting Study—New Joint And Skin (BERLISS-NEJS)

research POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)

June 2024

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

research Synthesis of avicequinone c and analogs toward the study of 5α-reductase inhibitory activity

January 2015

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

research Synthesis, Biological Evaluation and in silico Studies of Novel 5α-aza-Bhomo-3,5-secosteroids as Potential 5-reductase Inhibitors

October 2016 in “Letters in Drug Design & Discovery”

research Data from Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened

March 2023

The treatment was ineffective in humans.

Repurposing Finasteride And Serotonin Reuptake Inhibitors As Novel Antimicrobials: A Dual-Action Approach To Target Bacterial And Fungal Pathogens

research Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens

March 2026 in “Frontiers in Bioscience-Elite”

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

research Recessive Epidermolysis Bullosa Simplex Phenotype Reproduced in Vitro

20 citations , November 2003 in “American Journal Of Pathology”

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Lentiginous Melanoma: A Clinically Malignant Entity That Histopathologically Seems Benign. Case Study Harboring BRAF V600R Mutation

research Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation

1 citations , March 2015 in “Journal of the European Academy of Dermatology and Venereology”

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

research Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata

4 citations , April 2024 in “Journal of Drugs in Dermatology”

Ruxolitinib cream may help treat severe hair loss in children.

Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials

research 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials

September 2024 in “Journal of the American Academy of Dermatology”

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

research Bioavailability File: Bicalutamide

August 2025 in “Fabad Journal of Pharmaceutical Sciences”

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

research Baricitinib for the Treatment of Alopecia Areata

6 citations , May 2023 in “Drugs”

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

research Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

16 citations , January 2020 in “Annals of the rheumatic diseases”

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Prospective Clinical Study to Assess the Safety and Efficacy of Dravanti Beej Lepa (Local Application of Croton Tiglium) in Indralupta with Special Reference to Alopecia Areata

research PROSPECTIVE CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF DRAVANTI BEEJ LEPA (LOCAL APPLICATION OF CROTON TIGLIUM) IN INDRALUPTA W. S. R. TO ALOPECIA AREATA

July 2018 in “International journal of research - granthaalayah”

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

research Rejuvenating senescent hair follicles: a novel conjugated linoleic acid based nanovesicle approach to treat androgenic alopecia

January 2025

A new treatment using conjugated linoleic acid in nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.

research Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report

3 citations , January 2025 in “SAGE Open Medical Case Reports”

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

research Dupilumab: A Review of Present Indications and Off-Label Uses

50 citations , March 2021 in “Journal of investigational allergology & clinical immunology”

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

research Basement membrane Laminin and Type IV Collagen in Various Benign and Malignant Adnexal Tumors of the Skin: An Immunohistochemical Study

28 citations , October 1984 in “Journal of Investigative Dermatology”

research MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS

January 2016

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.